| 時間 | 主題 | ||||
|---|---|---|---|---|---|
From detrusor to urothelium - the pathophysiology of OAB
講者:
Karl-Erik Andersson
座長:
郭漢崇
|
Karl-Erik Andersson |
郭漢崇 |
|||
16:15 ~ 16:30 |
The superiority of beta 3-agonist in treatment of OAB in specific patient
講者:
Masayuki Takeda
座長:
郭漢崇
|
Masayuki Takeda |
郭漢崇 |
||
Mirabegron in the treatment of OAB – The Asian data
講者:
Myung-Soo Choo
座長:
郭漢崇
|
Myung-Soo Choo |
郭漢崇 |
|||
Combination of mirabegron with solifenacin - a better regimen for OAB？
講者:
莊燿吉
座長:
郭漢崇
|
莊燿吉 |
郭漢崇 |